AAO Journal Archive
- Classification of Vitreous Seeds in Retinoblastoma
- Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia
- Individualized Stabilization Criteria–Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion
- Correlation of Histologic Features with In Vivo Imaging of Reticular Pseudodrusen
- Pseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials
- Pharmacotherapies for Retinal Detachment
- Can Automated Imaging for Optic Disc and Retinal Nerve Fiber Layer Analysis Aid Glaucoma Detection?
- Suture Colonization Rate in Adjustable Strabismus Surgery
- Genetic and Dietary Factors Influencing the Progression of Nuclear Cataract
- Diagnostic Accuracy of Optical Coherence Tomography and Scanning Laser Tomography for Identifying Glaucoma in Myopic Eyes
- Details
The authors of “A Multicenter Prospective Cohort Study of Quality of Life and Economic Outcomes after Cataract Surgery in Vietnam” (Ophthalmology 2014;121:2138–46) would like to make the following correction to their article abstract.
- Details
Matoba et al (p. 451) observed a dendritiform keratopathy associated with topical ophthalmic exposure to the preservative polyquaternium-1 (PQ-1). For this case series, the researchers reviewed the records of 16 patients who were exposed to PQ-1 either via their use of contact lens disinfecting solutions (n = 13) or artificial tear products (n = 3). All of the patients experienced resolution of the dendritiform lesions within 2 to 6 weeks after their exposure to PQ-1 was eliminated. The authors emphasized the importance of differential diagnosis, as 10 of the 16 patients were initially treated for herpes simplex virus keratitis or acanthamoeba keratitis.
- Details
In their recent article, Watanabe et al1 explored relationships between corneal guttae and visual function in eyes with “mild” Fuchs' endothelial corneal dystrophy (FECD).1 They concluded that guttae affect quality of vision (QOV), and that “early endothelial keratoplasty for patients with mild FECD without severe edema should be considered to remove corneal guttae that affect the QOV parameters.”
- Details
Over the last decade, nonsteroidal anti-inflammatory drugs (NSAIDs) have been used increasingly in the setting of cataract surgery. Despite overwhelming acceptance of this practice, there is a paucity of data that clearly demonstrates the effectiveness of NSAIDs in improving long-term visual outcomes. According to a survey in 2012 by the American Society of Cataract and Refractive Surgery, 90% of its membership routinely prescribes an NSAID in addition to, but not as a replacement for, a corticosteroid during cataract surgery at a cost of nearly $200 per brand prescription and amounting to an annual societal cost approximating $540 million.